GSG Advisors’s Compugen CGEN Stock Holding History

GSG Advisors’s Portfolio CGEN Stock Details CGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$21.8K	Hold	10,245	–	–	0.01%	137
2025 Q4	$15.7K	Hold	10,245	–	–	﹤0.01%	134
2025 Q3	$16.4K	Hold	10,245	–	–	﹤0.01%	126
2025 Q2	$18.2K	Hold	10,245	–	–	0.01%	119
2025 Q1	$13.1K	Buy	+10,245	New	+$20K	﹤0.01%	112

Other funds holding CGEN

SCM

Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM

TFCM

Taylor Frigon Capital Management Scottsdale, Arizona $176M AUM 24.25% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

YLHM

Yelin Lapidot Holdings Management Tel Aviv, Israel $480M AUM 42.17% 1-Year Est. Return

GSG Advisors's CGEN Position: Q1 2026 in Review

GSG Advisors held its Compugen (CGEN) position steady in Q1 2026 at 10,245 shares worth $21.8K. The position accounts for 0.01% of the portfolio, ranked #137.

GSG Advisors first reported a position in CGEN in Q1 2025 and has held it in 5 quarters since. 78 funds tracked by Wall St. Rank hold CGEN as of Q1 2026.

GSG Advisors held 10,245 shares of Compugen worth $21.8K as of Q1 2026.
GSG Advisors left its Compugen share count unchanged in Q1 2026.
Compugen made up 0.01% of GSG Advisors's portfolio in Q1 2026, its #137 holding.
GSG Advisors first reported a position in Compugen in Q1 2025 and has held it in 5 quarters since.
78 funds tracked by Wall St. Rank held Compugen as of Q1 2026.

Based on GSG Advisors's 13F filing for Q1 2026, filed 13 May 2026.